Exploring the Application Efficacy of Artificial Intelligence (AI) Diagnostic Tools in Medical Imaging (MI) of Respiratory(R) Infectious (I) Disease (D)
Recruiting
N/A
Interventional Study
Respiratory Infectious Diseases
Artificial Intelligence
Medical Imaging
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 1 – 90
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 2,000 (estimated)
- Sponsor
- Huashan Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The early identification and severe warning of acute respiratory infectious diseases are of paramount importance. Utilizing effective means to make correct diagnoses of the source of infection at an early stage is the premise of all effective measures. AI-MID is a research initiative that uses artificial intelligence tools to assist in the clinical medical imaging diagnosis of respiratory diseases…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. 1-90 years old, gender not specified.
2. Exhibits symptoms of respiratory tract infection
3. Must have etiological examination results
4. Must have imaging data;
Exclusion Criteria:
1. Severe artifacts in medical images
2. Clinical diagnosis indicates concurrent pulmonary e…
Contacts